Document Detail


Advances and considerations in attention-deficit/hyperactivity disorder pharmacotherapy.
MedLine Citation:
PMID:  22009816     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Attention-deficit/hyperactivity disorder (ADHD) is a highly heritable neuropsychiatric disorder associated with significant impairments in occu¬pational, academic, neuropsychological, and social functioning. Central nervous system (CNS) stimulants are recommended as first-line medication therapy for children. CNS stimulants include formulations of methylphenidate and amphetamine derivatives and are available in a large variety of immediate- and extended-release preparations. Extended-release preparations are often preferred to limit drug administration during school or work and may help to limit side effects associated with rapid fluctuations in serum concentration. Stimulant medication is by far the most commonly used treatment in managing children with ADHD, 10-20% of those who take such medication do now show clinically significant improvements in their primary ADHD symptom. Even when a favorable response is obtained, some children experience side effects that are of sufficient occurrence and severity to prevent continued use of stimulant medication. In such instances or when families are unwilling to consider a stimulant, non-stimulant medications may be appealing. This review focuses on etiology, assessment and treatment of ADHD with various stimulant and non-stimulant agents.
Authors:
Mohammad Mohammadi; Shahin Akhondzadeh
Related Documents :
17288656 - Implementation and evaluation of a low-cost telemedicine station in the remote ecuadori...
10384436 - Sgml-based construction and automatic organization of comprehensive medical textbook on...
12575996 - Historical review: viruses, crystals and geodesic domes.
11187626 - The electronic medical record: using documents for information capture.
15799586 - An assessment of risk associated with the photography of microbiological materials.
12485206 - Ergot and triptan overuse in austria--an evaluation of clinical data and cost.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Acta medica Iranica     Volume:  49     ISSN:  1735-9694     ISO Abbreviation:  Acta Med Iran     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-10-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  14540050R     Medline TA:  Acta Med Iran     Country:  Iran    
Other Details:
Languages:  eng     Pagination:  487-98     Citation Subset:  IM    
Affiliation:
Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Acute paraplegia after general anesthesia.
Next Document:  Result of shelf acetabuloplasty in adults: 20 years of follow-up.